Dalton Greiner Hartman Maher & Co. decreased its stake in shares of Colony Capital Inc. (NYSE:CLNY) by 3.6% during the third quarter, Holdings Channel reports. The firm owned 1,371,671 shares of the company’s stock after selling 51,804 shares during the period. Colony Capital accounts for about 1.6% of Dalton Greiner Hartman Maher & Co.’s investment portfolio, making the stock its 5th largest position. Dalton Greiner Hartman Maher & Co.’s holdings in Colony Capital were worth $25,006,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Bank of Montreal Can acquired a new position in shares of Colony Capital during the second quarter valued at about $659,000. Montrusco Bolton Investments Inc. acquired a new position in shares of Colony Capital during the second quarter valued at about $641,000. Copper Rock Capital Partners LLC raised its position in shares of Colony Capital by 1.6% in the second quarter. Copper Rock Capital Partners LLC now owns 894,182 shares of the company’s stock valued at $13,726,000 after buying an additional 13,885 shares during the period. Geode Capital Management LLC raised its position in shares of Colony Capital by 23.4% in the first quarter. Geode Capital Management LLC now owns 838,312 shares of the company’s stock valued at $14,058,000 after buying an additional 159,234 shares during the period. Finally, Quadrature Capital Ltd acquired a new position in shares of Colony Capital during the first quarter valued at about $724,000. Institutional investors and hedge funds own 96.58% of the company’s stock.
Shares of Colony Capital Inc. (NYSE:CLNY) traded down 0.39% during trading on Thursday, hitting $17.89. The stock had a trading volume of 115,047 shares. The stock’s 50 day moving average price is $18.18 and its 200-day moving average price is $17.54. Colony Capital Inc. has a one year low of $14.73 and a one year high of $22.18. The stock has a market cap of $2.04 billion, a P/E ratio of 17.34 and a beta of 0.83.
Colony Capital (NYSE:CLNY) last announced its quarterly earnings results on Monday, August 8th. The company reported $0.67 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.23. Colony Capital had a net margin of 16.89% and a return on equity of 3.09%. During the same quarter last year, the company posted $0.44 EPS. Analysts expect that Colony Capital Inc. will post $2.01 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 28th. This represents a $1.60 annualized dividend and a yield of 8.91%. Colony Capital’s dividend payout ratio is currently 166.67%.
Several research analysts have issued reports on the company. Zacks Investment Research upgraded Colony Capital from a “sell” rating to a “hold” rating in a research report on Monday, September 12th. Wedbush started coverage on Colony Capital in a report on Wednesday, October 5th. They issued an “outperform” rating and a $26.00 price target for the company. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $24.20.
About Colony Capital
Colony Capital, Inc, formerly Colony Capital, Inc, is a global real estate and investment management company. The Company operates through five segments: Real Estate Equity, including Light industrial real estate assets and operating platform; Single-family residential rentals through an investment in Colony Starwood Homes and Other real estate equity investments; Real Estate Debt, which includes loan originations and acquisitions, and Investment Management, which includes investment management of the Company-sponsored funds and other investment vehicles.